|
|
|
Insider
Information: |
Black Bear Offshore Master Fund Lp |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
48,695,742 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,509,894,564 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
48,695,742 |
|
|
Total
Value |
$1,509,894,564 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neose Technologies Inc |
NTEC |
10% Owner |
2005-02-18 |
3,049,996 |
|
0 |
Premium* |
|
Seachange International Inc |
SEAC |
10% Owner |
2005-04-12 |
2,091,253 |
|
0 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-07-01 |
4,186,238 |
2005-11-03 |
0 |
Premium* |
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
7,971,542 |
2006-02-24 |
0 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2008-08-27 |
12,116,463 |
2008-04-03 |
0 |
Premium* |
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-07-01 |
9,366,039 |
2009-03-12 |
0 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2009-05-31 |
9,914,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
258 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-02-05 |
4 |
B |
$8.79 |
$349,657 |
D/D |
39,779 |
5,851,754 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-09-17 |
4 |
S |
$1.19 |
$48,988 |
D/D |
(41,100) |
9,364,802 |
0 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-02-22 |
4 |
B |
$5.49 |
$226,188 |
D/D |
41,200 |
9,299,073 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-01-27 |
4 |
B |
$0.46 |
$19,180 |
D/D |
41,443 |
9,314,510 |
2.37 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-07-17 |
4 |
B |
$16.04 |
$665,869 |
D/D |
41,513 |
7,554,281 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-03-07 |
4 |
B |
$20.70 |
$883,485 |
D/D |
42,600 |
5,386,821 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2006-06-08 |
4 |
B |
$8.15 |
$347,190 |
D/D |
42,600 |
5,362,551 |
2.45 |
- |
|
NTEC |
Neose Technologies Inc |
10% Owner |
|
2005-02-18 |
4 |
B |
$4.00 |
$173,200 |
D/D |
43,300 |
3,049,996 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-04-21 |
4 |
B |
$18.54 |
$842,699 |
D/D |
45,453 |
6,554,676 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-06-19 |
4 |
B |
$15.15 |
$695,385 |
D/D |
45,900 |
7,236,157 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-12-18 |
4 |
B |
$16.78 |
$771,385 |
D/D |
45,900 |
8,767,735 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2007-02-09 |
4 |
B |
$8.61 |
$401,226 |
D/D |
46,600 |
6,015,978 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-04-04 |
4 |
B |
$18.47 |
$871,784 |
D/D |
47,200 |
6,240,723 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-06-05 |
4 |
B |
$15.72 |
$748,544 |
D/D |
47,200 |
6,985,134 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2009-09-30 |
4 |
S |
$0.79 |
$37,572 |
D/D |
(47,385) |
7,971,542 |
0 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-06-11 |
4 |
S |
$5.00 |
$249,669 |
D/D |
(49,839) |
5,956,535 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-07 |
4 |
B |
$31.52 |
$1,576,000 |
D/D |
50,000 |
13,985,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-08 |
4 |
B |
$30.96 |
$1,548,000 |
D/D |
50,000 |
14,035,230 |
2.45 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
|
2008-04-17 |
4 |
B |
$30.35 |
$1,517,500 |
D/D |
50,000 |
14,780,698 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2007-02-14 |
4 |
B |
$5.73 |
$293,147 |
D/D |
51,160 |
9,135,466 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-05-24 |
4 |
B |
$14.99 |
$789,973 |
D/D |
52,700 |
6,937,934 |
2.45 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2009-06-10 |
4 |
S |
$5.09 |
$270,106 |
D/D |
(52,835) |
6,006,374 |
0 |
- |
|
SAVA |
Cassava Sciences Inc |
10% Owner |
|
2006-05-11 |
4 |
B |
$8.54 |
$463,722 |
D/D |
54,300 |
5,097,309 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-07-13 |
4/A |
B |
$16.53 |
$904,957 |
D/D |
54,327 |
7,417,582 |
2.45 |
- |
|
MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
|
2006-08-07 |
4 |
B |
$15.99 |
$893,569 |
D/D |
55,883 |
8,004,746 |
2.45 |
- |
|
258 Records found
|
|
Page 7 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|